Understanding how a genetic variant affects inflammation and infection response.
Interrogating the RIP kinase function of LRRK2 in chronic inflammation and susceptibility to infection.
This study is looking at how a certain gene linked to Parkinson's disease affects the immune system, especially how it can lead to more cell death during infections, which might help explain why some people get chronic inflammatory diseases; the findings could help patients understand how their genetics might influence their risk of infections and long-term health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-10580464 on NIH RePORTER |
What this research studies
This research investigates the role of a specific genetic variant associated with Parkinson's disease in influencing the immune response, particularly in macrophages. It focuses on how this variant leads to increased cell death during infections, which may contribute to chronic inflammatory diseases. By examining the mechanisms behind this process, the research aims to uncover the relationship between mitochondrial dysfunction and immune system behavior. Patients may benefit from insights into how their genetic makeup affects their susceptibility to infections and chronic conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with the LRRK2-G2019S genetic variant or those suffering from chronic inflammatory diseases.
Not a fit: Patients without the LRRK2-G2019S variant or those not affected by chronic inflammatory diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for patients with chronic inflammatory diseases and infections linked to genetic factors.
How similar studies have performed: Previous research has shown that understanding genetic variants can lead to significant advancements in treating chronic diseases, suggesting potential success for this approach.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Weindel, Catherine Gidley — Tulane University of Louisiana
- Study coordinator: Weindel, Catherine Gidley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.